✦ LIBER ✦

Childhood cancer in the united states: A geographical analysis of cases from the Pediatric Cooperative Clinical Trials Groups

✍ Scribed by Julie A. Ross; Richard K. Severson; Brad H. Pollock; Leslie L. Robison

Publisher: John Wiley and Sons
Year: 1996
Tongue: English
Weight: 648 KB
Volume: 77
Category: Article
ISSN: 0008-543X
DOI: 10.1002/(sici)1097-0142(19960101)77:1<201::aid-cncr32>3.0.co;2-7

No coin nor oath required. For personal study only.

✦ Synopsis

BACKGROUND.

After injuries, cancer is the leading cause of death in children younger than 15 years in the IJnited States. Despite dramatic increases in .?-year survival rates, more than 100,000 person-years of life are lost to childhood cancer each year. 'The exact proportion of pediatric cancer patients who receive care at centers that utilize up-to-date therapeutic protocols !such as those affiliated with the Childrens Cancer Group (CCG) or the Pediatric Oncology Group (PO(;)] remains unknown. The purpose of this study was to estimate the proportion and geographic distribution of childhood cancer patients in the United States who are seen at participating centers of the CCG and the POG.

📜 SIMILAR VOLUMES

Pediatric cancer in the United States. A

Pediatric cancer in the United States. A preliminary report of a collaborative study of the childrens cancer group and the pediatric oncology group

✍ Julie A. Ross; Richard K. Severson; Leslie L. Robison; Brad H. Pollock; Joseph P 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 555 KB

## Background: Cancer is the second leading cause of death in children younger than 15 years. although 5-year survival rates have increased dramatically for many childhood tumors, more than 100,000 person-years of life are lost to childhood cancer each year. the exact proportion of pediatric patien

Disparities in participation in cancer c

Disparities in participation in cancer clinical trials in the United States : A symptom of a healthcare system in crisis

✍ Gerardo Colon-Otero; Robert C. Smallridge; Lawrence A. Solberg Jr; Thomas D. Kei 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 234 KB

## Abstract Disparities in minorities' representation in cancer clinical trials have been shown only in adult populations, which suggest that the main causes of these disparities relate to health system‐based barriers, including issues of poverty (lack of insurance), poor access to trials, and an i

Cost analysis of filgrastim for the prev

Cost analysis of filgrastim for the prevention of neutropenia in pediatric T-cell leukemia and advanced lymphoblastic lymphoma: A case for prospective economic analysis in cooperative group trials

✍ Bennett, Charles L.; Stinson, Tammy J.; Lane, David; Amylon, Michael; Land, Vita 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 2 views

Background. Growth factor use has been shown to ameliorate chemotherapy-induced neutropenia, leading to shorter hospital stays and lower use of parenteral antibiotics, two costly areas of cancer treatment. Prior reports on pediatric patients have shown evidence of cost savings in some studies, but n

Results of the first phase 1 clinical tr

Results of the first phase 1 clinical trial of the HER-2/neu peptide (GP2) vaccine in disease-free breast cancer patients : United States Military Cancer Institute Clinical Trials Group Study I-04

✍ Mark G. Carmichael; Linda C. Benavides; Jarrod P. Holmes; Jeremy D. Gates; Eliza 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 424 KB 👁 1 views

Acute and chronic hepatitis in childhood

Acute and chronic hepatitis in childhood leukemia: A multicentric study from the italian pediatric cooperative group for therapy of acute leukemia (AIL-AIEOP)

✍ Locasciulli, A. ;Alberti, A. ;Rossetti, F. ;Santamaria, M. ;Santoro, N. ;Madon, 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 387 KB

The incidence of acute and chronic liver damage and its relation to hepatitis B virus (HBV) infection was evaluated in 164 consecutive children with acute leukemia seen in ten Italian hemato-pediatric units. Thirteen out of 164 children (7.9%) had acute hepatitis (AH) during treatment, while 8/90 (8

Clinical significance of Philadelphia ch

Clinical significance of Philadelphia chromosome positive pediatric acute lymphoblastic leukemia in the context of contemporary intensive therapies : A report from the Children's Cancer Group

✍ Fatih M. Uckun; James B. Nachman; Harland N. Sather; Martha G. Sensel; Peter Kra 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB 👁 3 views

## BACKGROUND. Children with Philadelphia (Ph) chromosome positive ( ϩ ) acute lymphoblastic leukemia (ALL) represent a subgroup at very high risk for treatment failure. In this report, the authors assessed the outcome of Ph ϩ ALL in a large cohort of children treated on contemporary intensive che